Drug-sensitive bacteria can develop resistance when part of microbial communities, utilizing cross-protection mechanisms. Many human medications can directly inhibit the growth and disrupt the function of bacteria in our gut microbiome. However, researchers at EMBL Heidelberg have found that this impact is diminished when these bacteria form communities. In a first-of-its-kind study, researchers from EMBL […]
Source link